Raymond James Financial’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$69.5M Buy
195,128
+36,180
+23% +$11.6M 0.02% 746
2026
Q2
$76.8M Buy
158,948
+61,792
+64% +$16.4M 0.02% 694
2026
Q1
$10.6M Buy
97,156
+193
+0.2% +$27.5K ﹤0.01% 1965
2025
Q4
$16.1M Sell
96,963
-188,968
-66% -$31.6M 0.01% 1595
2025
Q3
$56M Buy
285,931
+70,022
+32% +$11.5M 0.02% 739
2025
Q2
$19.5M Buy
215,909
+172,814
+401% +$13.7M 0.01% 1392
2025
Q1
$2.57M Sell
43,095
-221,908
-84% -$20.5M ﹤0.01% 2815
2024
Q4
$35.1M Buy
+265,003
New +$24.9M 0.01% 933

Other funds holding ALAB

Raymond James Financial's ALAB Position: Q3 2026 in Review

Raymond James Financial increased its Astera Labs (ALAB) stake by 23% in Q3 2026, buying an estimated $11.6M and bringing the position to 195,128 shares worth $69.5M. The position accounts for 0.02% of the portfolio, ranked #746.

Raymond James Financial first reported a position in ALAB in Q4 2024 and has held it in 8 quarters since. The position peaked at $76.8M in Q2 2026. 1,001 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.

  • Raymond James Financial held 195,128 shares of Astera Labs worth $69.5M as of Q3 2026.
  • Raymond James Financial bought 36,180 Astera Labs shares in Q3 2026, an estimated $11.6M.
  • Astera Labs made up 0.02% of Raymond James Financial's portfolio in Q3 2026, its #746 holding.
  • Raymond James Financial first reported a position in Astera Labs in Q4 2024 and has held it in 8 quarters since.
  • Raymond James Financial's Astera Labs position peaked at $76.8M in Q2 2026.
  • 1,001 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.

Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.